10 May 2019
Impact Healthcare REIT plc
("Impact" or the "Company")
DIRECTOR DECLARATION
Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which provides investors with exposure to a diversified portfolio of UK healthcare real estate assets, in particular residential care homes, announces that Rosemary Boot, Non-Executive Director of the Company, has been appointed today as a non-executive director of Urban&Civic plc.
This announcement is made in accordance with Listing Rule 9.6.14R(2).
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP Mahesh Patel Andrew Cowley |
via Maitland/AMO |
|
|
Winterflood Securities Limited Joe Winkley Neil Langford |
Tel: 020 3100 0000 |
|
|
RBC Capital Markets Rupert Walford Matthew Coakes |
Tel: 020 7653 4000 |
|
|
Maitland/AMO (Communications Adviser) James Benjamin Andy Donald |
Tel: 020 7379 5151 Email: impacthealth-maitland@maitland.co.uk |
The Company's LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at www.impactreit.uk.
NOTES:
Impact Healthcare REIT plc is a real estate investment trust ("REIT") which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of UK healthcare real estate opportunities, in particular residential care homes. The Group's investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.
The Group has now declared or paid eight quarterly dividends of 1.50 pence per share or greater since IPO on 7 March 2017.
The Company will seek to grow the target dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.
The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium fund segment, on 8 February 2019.